2
VOL. 110, NO. 1 JANUARY 1998 LETTER TO THE EDITOR 97 photostability for oxybenzone with a 5% solution after simulated sunlight exposure over 4 h using FT Raman spectroscopy and HPLC; however, careful analysis of their data on the recovery of oxybenzone shows 7.7% photodegradation (i.e., 2 3 10 –2 M). The loss of aromaticity of oxybenzone after UV exposure can be followed by standardized FT Raman spectroscopy, indicating the formation of a semiquinone intermediate (Fig 2). In addition, we were able to show that oxybenzone, upon UVA exposure, oxidizes the essential cofactor (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin (6BH 4 ), whereas UVA alone cannot promote this reaction. Under certain conditions, this oxidation can be cytotoxic to epidermal melanocytes (Schallreuter et al, 1994; Moore et al, 1997). The FTIR experiment presented in Dr. Santoro’s letter shows one experiment using the pure stable phenol form of oxybenzone during the entire study without consideration of the unstable phenolate anion. The stable phenol form of oxybenzone is in equlibrium with the unstable phenolate which undergoes photo-oxidation yielding a semiquinone radical intermediate. This free radical can react with O 2 producing O 2 and oxybenzone semiquinone. This proposed reaction pathway mimics the established formation of the ubiquinone semiquinone radical produced as intermediate in the electron transport chain. Therefore Dr. Santoro’s findings on the stability are obtained Raman Spectroscopic Studies Showing the UV Stability of Oxybenzone To the Editor: In an article on the photostability of the sunscreen oxybenzone recently published in this Journal it was concluded on the basis of Raman spectroscopic measurements alone that this sunscreen is not photostable (Schallreuter et al, 1996). This finding is not only extraordinary, it also contradicts our own findings as well as published stability data (Roscher et al, 1994). As our department uses Raman spectroscopy for a wide variety of sunscreen analyses, 1,2 we were interested in clarifying this contradiction and conducted our own experiments. Using Raman spectroscopy, we first analyzed a commercial sample of Soltan facial cream SPF25. The resulting Raman spectrum Figure 1. Raman spectra of (a) Soltan facial cream, (b) pure oxybenzone, and (c) Soltan facial cream spiked with 3% oxybenzone. under special conditions and cannot be compared with commercial oxybenzone formulations that will always contain an equilibrium of the phenol and phenolate forms. In summary we conclude that oxybenzone in formulations is a photo-active molecule that under oxidative conditions can produce potentially damaging electrophiles in the skin (Sundaram et al, 1990; Schallreuter et al, 1996; Moore et al, 1997). Karin U. Schallreuter, Jeremy Moore, John M. Wood Clinical and Experimental Dermatology, Department of Biomedical Sciences, University of Bradford, Bradford, U.K. REFERENCES Moore J, Ko ¨rner C, Hibberts NA, Wood JM, Schallreuter KU: Direct evidence for oxidation of oxybenzone in the human epidermis. J Invest Dermatol 108:4, 666, 770, 1997 Schallreuter KU, Bu ¨ttner G, Pittelkow MR, Wood JM, Swanson NN, Ko ¨rner C: Cytotoxicity of 6-biopterin to human melanocytes. Biochem Biophys Res Communs 204:1, 43–48, 1994 Schallreuter KU, Wood JM, Farwell DW, Moore J, Edwards HGM: Oxybenzone oxidation following solar irradiation of skin: Photoprotection versus antioxidant inactivation. J Invest Dermatol 106:583–586, 1996 Sundaram C, Ko ¨ster W, Schallreuter KU: The effect of UV-radiation and sun blockers on free radical defense in human and guinea pig epidermis. Archiv Dermatol Res 282:526– 531, 1990 (Fig 1a) agreed very well with the spectrum of Schallreuter et al. Surprisingly, neither spectrum showed the Raman band at 1000 per cm that is expected for monosubstituted aromatic compounds and is found in the spectrum of pure oxybenzone (Fig 1b); however, we did observe this typical Raman signal after spiking the Soltan cream sample with 3% oxybenzone (Fig 1c). Closer inspection of the spectra in Fig 1(b,c) revealed several additional bands typical of oxybenzone. Because the Raman measurement provided no clear proof of the presence of oxybenzone in the commercial Soltan facial cream sample, we then performed a qualitative and quantitative analysis of the sample using high performance liquid chromatography. As expected, these results likewise provided no indication of the presence of oxybenzone. They did, however, show the presence of octyl methoxycinnamate (6%) and butyl methoxydibenzoylmethane (2.8%). It therefore seemed very likely that the sun cream used by Schallreuter et al did not contain any oxybenzone, as these authors assumed. This led us to study the stability of pure oxybenzone and oxybenzone in an oil in water stearate emulsion after UV irradiation (4 h, simulated midday sun). Although a small percentage of oxybenzone was degraded, it is impossible to conclude a general photoinstability of the substance. It is also impossible to make any statements on the stability of oxybenzone on the basis of the studies by Schallreuter et al because this sunscreen most likely was not present in the cream sample they investigated. Hence all other conclusions on the further reaction of the proposed semiquinone are highly questionable. Claudius Rapp, Guido Heinsohn, Ulrich Hintze Central Analytical Department, Beiersdorf AG, Hamburg, Germany 1 Heinsohn G, Rapp C, Gers-Berlag H: FT-Raman spectroscopy a suitable method for photostability testing of sunscreens. International Conference on Photobiology, Vienna, September 1–6, 1996 2 Rapp C, Heinsohn G, Hintze U: Raman spectroscopy – a rapid method for the analysis of sunscreens. Paper presented at the Pittsburgh Conference on Analytical Chemistry and Applied Spectroscopy in Atlanta, March 1997.

Raman Spectroscopic Studies Showing the UV Stability of Oxybenzone

  • Upload
    ulrich

  • View
    215

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Raman Spectroscopic Studies Showing the UV Stability of Oxybenzone

VOL. 110, NO. 1 JANUARY 1998 LETTER TO THE EDITOR 97

photostability for oxybenzone with a 5% solution after simulatedsunlight exposure over 4 h using FT Raman spectroscopy and HPLC;however, careful analysis of their data on the recovery of oxybenzoneshows 7.7% photodegradation (i.e., 2 3 10–2 M). The loss ofaromaticity of oxybenzone after UV exposure can be followed bystandardized FT Raman spectroscopy, indicating the formation of asemiquinone intermediate (Fig 2). In addition, we were able to showthat oxybenzone, upon UVA exposure, oxidizes the essential cofactor(6R)-L-erythro-5,6,7,8-tetrahydrobiopterin (6BH4), whereas UVAalone cannot promote this reaction. Under certain conditions, thisoxidation can be cytotoxic to epidermal melanocytes (Schallreuter et al,1994; Moore et al, 1997).

The FTIR experiment presented in Dr. Santoro’s letter shows oneexperiment using the pure stable phenol form of oxybenzone duringthe entire study without consideration of the unstable phenolate anion.The stable phenol form of oxybenzone is in equlibrium with theunstable phenolate which undergoes photo-oxidation yielding asemiquinone radical intermediate. This free radical can react with O2producing O2

– and oxybenzone semiquinone. This proposed reactionpathway mimics the established formation of the ubiquinonesemiquinone radical produced as intermediate in the electron transportchain. Therefore Dr. Santoro’s findings on the stability are obtained

Raman Spectroscopic Studies Showing the UV Stability ofOxybenzone

To the Editor:In an article on the photostability of the sunscreen oxybenzonerecently published in this Journal it was concluded on the basis ofRaman spectroscopic measurements alone that this sunscreen is notphotostable (Schallreuter et al, 1996). This finding is not onlyextraordinary, it also contradicts our own findings as well aspublished stability data (Roscher et al, 1994). As our departmentuses Raman spectroscopy for a wide variety of sunscreen analyses,1,2

we were interested in clarifying this contradiction and conductedour own experiments.

Using Raman spectroscopy, we first analyzed a commercial sampleof Soltan facial cream SPF25. The resulting Raman spectrum

Figure 1. Raman spectra of (a) Soltan facial cream, (b) pure oxybenzone,and (c) Soltan facial cream spiked with 3% oxybenzone.

under special conditions and cannot be compared with commercialoxybenzone formulations that will always contain an equilibrium ofthe phenol and phenolate forms.

In summary we conclude that oxybenzone in formulations is aphoto-active molecule that under oxidative conditions can producepotentially damaging electrophiles in the skin (Sundaram et al, 1990;Schallreuter et al, 1996; Moore et al, 1997).

Karin U. Schallreuter, Jeremy Moore, John M. WoodClinical and Experimental Dermatology, Department of Biomedical

Sciences, University of Bradford, Bradford, U.K.

REFERENCES

Moore J, Korner C, Hibberts NA, Wood JM, Schallreuter KU: Direct evidence for oxidationof oxybenzone in the human epidermis. J Invest Dermatol 108:4, 666, 770, 1997

Schallreuter KU, Buttner G, Pittelkow MR, Wood JM, Swanson NN, Korner C:Cytotoxicity of 6-biopterin to human melanocytes. Biochem Biophys Res Communs204:1, 43–48, 1994

Schallreuter KU, Wood JM, Farwell DW, Moore J, Edwards HGM: Oxybenzone oxidationfollowing solar irradiation of skin: Photoprotection versus antioxidant inactivation.J Invest Dermatol 106:583–586, 1996

Sundaram C, Koster W, Schallreuter KU: The effect of UV-radiation and sun blockers onfree radical defense in human and guinea pig epidermis. Archiv Dermatol Res 282:526–531, 1990

(Fig 1a) agreed very well with the spectrum of Schallreuter et al.Surprisingly, neither spectrum showed the Raman band at 1000 percm that is expected for monosubstituted aromatic compounds andis found in the spectrum of pure oxybenzone (Fig 1b); however,we did observe this typical Raman signal after spiking the Soltancream sample with 3% oxybenzone (Fig 1c). Closer inspection ofthe spectra in Fig 1(b,c) revealed several additional bands typical ofoxybenzone.

Because the Raman measurement provided no clear proof of thepresence of oxybenzone in the commercial Soltan facial creamsample, we then performed a qualitative and quantitative analysis ofthe sample using high performance liquid chromatography. Asexpected, these results likewise provided no indication of thepresence of oxybenzone. They did, however, show the presence ofoctyl methoxycinnamate (6%) and butyl methoxydibenzoylmethane(2.8%).

It therefore seemed very likely that the sun cream used bySchallreuter et al did not contain any oxybenzone, as these authorsassumed. This led us to study the stability of pure oxybenzone andoxybenzone in an oil in water stearate emulsion after UV irradiation(4 h, simulated midday sun). Although a small percentage ofoxybenzone was degraded, it is impossible to conclude a generalphotoinstability of the substance.

It is also impossible to make any statements on the stability ofoxybenzone on the basis of the studies by Schallreuter et al becausethis sunscreen most likely was not present in the cream samplethey investigated. Hence all other conclusions on the further reactionof the proposed semiquinone are highly questionable.

Claudius Rapp, Guido Heinsohn, Ulrich HintzeCentral Analytical Department, Beiersdorf AG, Hamburg,

Germany

1Heinsohn G, Rapp C, Gers-Berlag H: FT-Raman spectroscopy – asuitable method for photostability testing of sunscreens. InternationalConference on Photobiology, Vienna, September 1–6, 1996

2Rapp C, Heinsohn G, Hintze U: Raman spectroscopy – a rapid methodfor the analysis of sunscreens. Paper presented at the Pittsburgh Conferenceon Analytical Chemistry and Applied Spectroscopy in Atlanta, March 1997.

Page 2: Raman Spectroscopic Studies Showing the UV Stability of Oxybenzone

98 LETTER TO THE EDITOR THE JOURNAL OF INVESTIGATIVE DERMATOLOGY

REFERENCES

Roscher NM, Lindemann MKO, Kong SB, Cho CG, Jiang P: Photodecompositionof several compounds commonly used as sunscreen agents. J Photochem PhotobiolA Chem 80:417–421, 1994

Schallreuter KU, Wood JM, Farwell DW, Moore J, Edwards HJM: OxybenzoneOxidation Following Solar Irradiation of Skin: Photoprotection versus AntioxidantInactivation. J Invest Dermatol 106:583–586, 1996

Reply:We welcome the opportunity to comment on the correspondencefrom Dr. Rapp et al regarding the presence or absence of oxybenzonein the Soltan facial cream that we used in our publication(Schallreuter et al, 1996). The Beiersdorf group have raised severalpoints already posed in a previous letter to the editor by Dr.Santoro from Sigma Chemical Company. Even though Soltan facialcream lists oxybenzone as an ingredient we agree with Dr. Rappthat oxybenzone is absent from recent commercially availableformulations; however, the preparation we purchased in 1995did contain oxybenzone as proved by high performance liquidchromatography analysis (see reply to Dr. Santoro’s letter). The lossof the phenyl ring breathing band at 1000 cm–1 in the latterformulation must be accounted for by π–π interactions with otheraromatic compounds in the Soltan cream. In our opinion theaddition of 3% oxybenzone to recent formulations of Soltan facialcream would exceed the π–π saturation by methoxycinnamate andespecially by methoxydibenzoyl methane (2.8%), yielding theincreased band for free oxybenzone at 1000 cm–1, whereas in theformulation that we used the concentration of oxybenzone wassignificantly lower than the other aromatic sunscreens present.

Since our paper was published in 1996, oxybenzone appears tohave been removed from Soltan facial cream even though it is stilllisted as an ingredient.

The most important point raised is the stability of oxybenzoneto ultraviolet irradiation. The photoreduction of aryl ketonessubstituted at position 2, as in the case of oxybenzone, is wellestablished and occurs via intramolecular hydrogen abstraction, aswell as by intermolecular processes, by H-donors such asethylenediamine tetra-acetic acid (Fig 1; Wayne and Wayne, 1996).Ethylenediamine tetra-acetic acid is a common ingredient of sunprotection formulations. We have reported recently severalexperiments showing the instability of oxybenzone to ultravioletirradiation yielding semiquinone radical intermediates.1 The posterpresented by Heinsohn et al clearly shows 7.7% photodegradationof a 5% solution of oxybenzone by 4 h simulated midday sun. Thisphotoreduction represents 20 3 10–3 M photogenerated highly activeelectrophile.1 This concentration could be dangerous to the viability

1Moore J, Korner C, Hibberts NA, Wood JM, Schallreuter KU: Directevidence for oxidation of oxybenzone in the human epidermis. J InvestDermatol 108:666, 1997 (abstr. 770).

Dynamic Changes in Intracellular Location of Metallothioneinin Rat Keratinocytes After Ultraviolet-B Irradiation

To the Editor:Ultraviolet B (UVB) is a causative factor of sunburn cell (SBC)formation and epidermal hyperplasia. We have shown that an increase in

Manuscript received July 21, 1997; accepted for publication September8, 1997.

Abbreviations: IF, immunofluorescence; MT, metallothionein; SBC,sunburn cell.

Figure 1. Mechanisms for the generation of electrophiles by intramolecularand intermolecular processes catalyzed by UV-mediated homolytic cleavageof the phenolic O–H and C–H bonds, respectively, followed by H-atom abstraction.

of melanocytes due to the oxidation of the pterins to 6-biopterin,by semiquinone radicals, which has been shown to be cytotoxic tomelanocytes with LD50 5 10–7 M (Schallreuter et al, 1994).1

The generation of 20 3 10–3 M electrophiles cannot be ignoredbecause concentrations in this range are high at the cellular leveland are therefore potentially harmful.2

Karin U. Schallreuter, Jeremy Moore, John M. WoodDepartment of Biomedical Sciences, University of Bradford

Bradford, West Yorks, U.K.

REFERENCES

Schallreuter KU, Buttner G, Pittelkow MR, Wood JM, Swanson NN, Korner C:Cytotoxicity of 6-biopterin to human melanocytes. Biochem Biophys Res Commun204:43–48, 1994

Schallreuter KU, Wood JM, Farwell DW, Moore J, Edwards HGM: Oxybenzoneoxidation following solar irradiation of skin: photoprotection versus anti-oxidantinactivation. J Invest Dermatol 106:583–586, 1996

Wayne CE, Wayne RP: Photochemistry. Science Publications, Oxford, 1996, pp. 29–30

2Since our reply was submitted for publication Hayden et al have studiedthe systemic absorption and oxidation of topically applied oxybenzone (Lancet350:863–864, 1997). Urinalysis yielded 2,3,4,tri hydroxy-benzophenone and2,4,dihydroxy-benzophenone representative of 2% of the topically appliedsunscreen. These electrophiles undergo oxidation and form Michael additionconjugates. The authors state ‘‘It would be prudent not to apply oxybenzoneto large surface areas of skin for extended and repeated periods of time.’’

metallothionein (MT) synthesis induced by cadmium (Cd21) treatmentsuppresses UVB-mediated SBC formation in mouse skin and enhancesUVB resistance in cultured keratinocytes (Hanada et al, 1991a), becauseMT is a cysteine-rich protein with scavenging activity (Thornalley andVasak, 1985) that is readily inducible by exposure to heavy metals,including Cd21; however, there has been no clear evidence for cellularlocalization of Cd21-induced MT in keratinocytes.

In order to understand the details of the photoprotective mechanismin Cd21-treated keratinocytes, the present study was designed to